The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Expansion Is Predicted For The Antacids Market Between 2026 And 2030?
The antacids market size has demonstrated steady expansion over recent years. It is anticipated to grow from $9.94 billion in 2025 to $10.18 billion in 2026, achieving a compound annual growth rate (CAGR) of 2.5%. This historical growth can be attributed to the rising occurrence of acid reflux and heartburn, greater awareness regarding digestive health, the proliferation of retail pharmacy networks, the introduction of proton pump inhibitors, and the increased availability of liquid and chewable formulations.
The antacids market size is projected for consistent expansion in the upcoming years. Its value is expected to reach $11.57 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 3.3%. This anticipated growth is largely driven by factors such as the increasing integration of personalized medicine, growing consumer demand for natural and herbal antacids, the expansion of e-pharmacy and digital sales channels, advancements in drug delivery technologies, and market penetration into emerging economies. Key trends for the forecast period include greater over-the-counter accessibility, a rise in multi-ingredient antacid formulations, an increased emphasis on pediatric and geriatric healthcare, the development of home healthcare provisions, and a discernible shift toward natural and herbal antacid products.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2415&type=smp
Which Growth Drivers Are Contributing To The Progress Of The Antacids Market?
The rising occurrence of inflammatory bowel disease is anticipated to fuel the expansion of the antacids market. Inflammatory bowel disease (IBD) encompasses conditions marked by persistent inflammation within the digestive system. Antacids are pharmaceuticals intended to control stomach acid and are widely utilized for treating heartburn and indigestion. For example, data from the International Foundation for Gastrointestinal Disorders (IFFGD), a US-based non-profit education and research organization, indicates that approximately 5–10% of the global populace will have IBS in 2023, and between 25 and 45 million people in the United States are impacted by IBS. Furthermore, a survey conducted by the American Gastroenterological Association across 33 countries spanning 6 continents, investigating the prevalence and related factors of functional gastrointestinal disorders, revealed that among 73,076 adult participants, over 40% of individuals globally suffer from functional gastrointestinal disorders (FGID), impacting their quality of life and healthcare utilization. Consequently, the rising incidence of inflammatory bowel disease is expected to propel the expansion of the antacids market in the future.
Which Market Segments Are Examined In The Antacids Market Study?
The antacids market covered in this report is segmented –
1) By Drug Class: Proton Pump Inhibitors, H2 Antagonist, Acid Neutralizers, Pro-Motility Agents
2) By Formulation Type: Tablet, Liquid, Powder, Other Formulation Types
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels
Subsegments:
1) By Proton Pump Inhibitors (PPIs): Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, Rabeprazole
2) By H2 Antagonists: Ranitidine, Famotidine, Cimetidine, Nizatidine
3) By Acid Neutralizers: Antacids, Sodium Bicarbonate
4) By Pro-Motility Agents: Metoclopramide, Domperidone
Which Trends Are Influencing The Antacids Market?
Major companies operating in the antacids market are introducing new products, including various antacid flavors, to boost their profitability. Antacid flavors refer to the diverse taste options offered for antacid products. For instance, in March 2023, Wonderbelly, a US-based digestive medicine company, launched three antacid flavors: Fruity Cereal, available exclusively at Target stores, Strawberry Milkshake, and Watermelon Mint. Wonderbelly Antacid contains calcium carbonate, the same active ingredient as other brands. However, it distinguishes itself by being a non-GMO and vegan product, free from talc, dyes, gluten, dairy, common allergens, synthetic sweeteners, artificial flavors, parabens, and preservatives. These products were developed collaboratively with gastroenterologists and pharmaceutical manufacturers to ensure their quality.
Leading companies within the antacids market are innovating new offerings, such as anti-reflux antacids, to meet the increasing consumer demand for effective heartburn and acid reflux solutions. Anti-reflux antacids are medications specifically designed to alleviate symptoms of gastroesophageal reflux disease (GERD) and related conditions by neutralizing stomach acid. For example, in June 2024, Akums Drugs and Pharmaceuticals, an India-based pharmaceutical preparation manufacturing company, introduced a new chewable tablet for heartburn relief, which combines sodium alginate and potassium bicarbonate. Approved by the Drugs Controller General of India (DCGI), this dual-action formulation is intended to provide effective relief from gastroesophageal reflux disease (GERD) symptoms. Sodium alginate forms a protective gel barrier to prevent acid reflux, while potassium bicarbonate neutralizes stomach acid for immediate relief.
Who Are The Primary Competitors In The Antacids Market?
Major companies operating in the antacids market are Walmart Equate LLC, Private Label, Pfizer Inc, Bayer AG, Sanofi S.A., Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Reckitt Benckiser Group plc, WellSpring Pharmaceutical Corporation, Xiuzheng Pharmaceutical Group Company Limited, Bausch Health Companies Inc., Sun Pharmaceuticals Industries Ltd., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Alkem Laboratories Ltd., Conba Group Co. Ltd., Chattem Chemicals Inc., China Resources Sanjiu Medical & Pharmaceutical Co. Ltd., Thornton and Ross Ltd., McNeil Consumer Pharmaceuticals Co., Advance Pharmaceutical Inc.
Read the full antacids market report here:
https://www.thebusinessresearchcompany.com/report/antacids-global-market-report
What Are The Leading Geographic Regions In The Antacids Market?
North America was the largest region in the antacids market in 2025. The Middle East is expected to be the fastest-growing region in the global antacids market share. The regions covered in the antacids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Antacids Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=2415&type=smp
Browse Through More Reports Similar to the Global Antacids Market 2026, By The Business Research Company
Antacids Market Report 2026
https://www.thebusinessresearchcompany.com/report/antacids-global-market-report
Anthracycline Market Report 2026
https://www.thebusinessresearchcompany.com/report/anthracycline-global-market-report
Arachidonic Acid Market Report 2026
https://www.thebusinessresearchcompany.com/report/arachidonic-acid-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model